• About us
• Contact

Advertisement

Person › Details

Carsten Rudolph (Ethris GmbH)

Rudolph, Carsten (Ethris 201301 Managing Director + Co-Founder)

 

	Organisation	Ethris GmbH
	Product	SNIM®RNA technology

Record changed: 2024-06-27

Advertisement

More documents for Carsten Rudolph

• [1] Ethris GmbH. (6/18/24). "Press Release: Cipla EU to Invest an Additional EUR 3 Million in Ethris". Mumbai & Munich....
• [2] Ethris GmbH. (6/18/24). "Press Release: Ethris Announces $5 Million in Funding to Prepare Lead Candidate ETH47 for Phase 2 Stud". Munich....
• [3] Ethris GmbH. (12/29/22). "Press Release: Cipla EU to Invest EUR 15 million in Ethris, Initiating a Strategic Collaboration". Mumbai & Munich....
• [4] Ethris GmbH. (12/21/22). "Press Release: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses". Munich....
• [5] Ethris GmbH. (2/1/22). "Press Release: Ethris Raises $26.3 Million Series B to Advance Pipeline of mRNA-based Therapeutics for Respiratory Diseases". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.